Ameritas Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.4K | Hold |
28,729
| – | – | ﹤0.01% | 2193 |
|
2025
Q1 | $95.7K | Hold |
28,729
| – | – | ﹤0.01% | 1741 |
|
2024
Q4 | $213K | Buy |
28,729
+3,924
| +16% | +$29K | 0.01% | 1286 |
|
2024
Q3 | $233K | Hold |
24,805
| – | – | 0.01% | 1213 |
|
2024
Q2 | $199K | Buy |
24,805
+1,816
| +8% | +$14.6K | 0.01% | 1269 |
|
2024
Q1 | $341K | Hold |
22,989
| – | – | 0.01% | 975 |
|
2023
Q4 | $187K | Hold |
22,989
| – | – | 0.01% | 1304 |
|
2023
Q3 | $105K | Buy |
22,989
+5,809
| +34% | +$26.4K | ﹤0.01% | 1627 |
|
2023
Q2 | $121K | Buy |
17,180
+5,872
| +52% | +$41.3K | ﹤0.01% | 1471 |
|
2023
Q1 | $69.1K | Hold |
11,308
| – | – | ﹤0.01% | 1773 |
|
2022
Q4 | $79.2K | Hold |
11,308
| – | – | ﹤0.01% | 1753 |
|
2022
Q3 | $108K | Hold |
11,308
| – | – | ﹤0.01% | 1431 |
|
2022
Q2 | $124K | Buy |
+11,308
| New | +$124K | 0.01% | 1361 |
|
2020
Q2 | – | Sell |
-10,222
| Closed | -$306K | – | 3096 |
|
2020
Q1 | $306K | Buy |
10,222
+147
| +1% | +$4.4K | 0.02% | 773 |
|
2019
Q4 | $279K | Buy |
10,075
+308
| +3% | +$8.53K | 0.01% | 920 |
|
2019
Q3 | $178K | Hold |
9,767
| – | – | 0.01% | 1115 |
|
2019
Q2 | $239K | Buy |
9,767
+1,009
| +12% | +$24.7K | 0.01% | 976 |
|
2019
Q1 | $83K | Hold |
8,758
| – | – | ﹤0.01% | 1587 |
|
2018
Q4 | $78K | Buy |
8,758
+1,750
| +25% | +$15.6K | ﹤0.01% | 1551 |
|
2018
Q3 | $79K | Hold |
7,008
| – | – | ﹤0.01% | 1706 |
|
2018
Q2 | $90K | Buy |
7,008
+785
| +13% | +$10.1K | ﹤0.01% | 1609 |
|
2018
Q1 | $105K | Buy |
6,223
+1,632
| +36% | +$27.5K | 0.01% | 1457 |
|
2017
Q4 | $37K | Hold |
4,591
| – | – | ﹤0.01% | 2091 |
|
2017
Q3 | $26K | Hold |
4,591
| – | – | ﹤0.01% | 2279 |
|
2017
Q2 | $34K | Hold |
4,591
| – | – | ﹤0.01% | 2148 |
|
2017
Q1 | $34K | Buy |
+4,591
| New | +$34K | ﹤0.01% | 2090 |
|